Patients with elevated serum CEA levels, poor differentiation/undifferentiated tumor status, < 12 lymph nodes removed, and lymph node metastases were 52.2%, 21.8%, 19.3%, and 56.9%, respectively. This evidence concerns the gene CEACAM5 and neoplasm.